• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LMNA 通过调节肝癌的增殖和迁移能力发挥癌基因作用。

LMNA functions as an oncogene in hepatocellular carcinoma by regulating the proliferation and migration ability.

机构信息

College of Biotechnology, Guilin Medical University, Guilin, China.

College of Stomatology, Guangxi Medical University, Nanning, China.

出版信息

J Cell Mol Med. 2020 Oct;24(20):12008-12019. doi: 10.1111/jcmm.15829. Epub 2020 Sep 8.

DOI:10.1111/jcmm.15829
PMID:32896989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7578910/
Abstract

The role of the LMNA gene in the development and progression of hepatocellular carcinoma (HCC) and the associated molecular mechanism is not yet clear. Therefore, the purpose of this study was to evaluate the relationship between LMNA and HCC. LMNA gene expression in normal tissues and corresponding tumours was evaluated and the Kaplan-Meier survival analysis was performed. Next, the LMNA gene was knocked out in the 293T and HepG2 cell lines using the CRISPR/Cas9 technique. Subsequently, the proliferation, migration and colony formation rate of the two LMNA knockout cell lines were analysed. Finally, the molecular mechanism affecting the tumorigenesis due to the loss of the LMNA gene was evaluated. The results showed that the LMNA gene was abnormally expressed in many tumours, and the survival rate of the HCC patients with a high expression of the LMNA gene was significantly reduced compared with the rate in patients with a low LMNA expression. The knockout of the LMNA gene in the HCC cell line HepG2 resulted in a decreased tumorigenicity, up-regulation of the P16 expression and down-regulation of the CDK1 expression. These findings suggested that LMNA might function as an oncogene in HCC and provided a potential new target for the diagnosis and treatment of HCC.

摘要

LMNA 基因在肝细胞癌(HCC)的发生发展及相关分子机制中的作用尚不清楚。因此,本研究旨在探讨 LMNA 与 HCC 的关系。评估了正常组织和相应肿瘤中 LMNA 基因的表达,并进行了 Kaplan-Meier 生存分析。接下来,使用 CRISPR/Cas9 技术敲除 293T 和 HepG2 细胞系中的 LMNA 基因。然后分析了这两条 LMNA 敲除细胞系的增殖、迁移和集落形成率。最后,评估了由于 LMNA 基因缺失而影响肿瘤发生的分子机制。结果表明,LMNA 基因在多种肿瘤中异常表达,且高表达 LMNA 基因的 HCC 患者的生存率明显低于低表达 LMNA 的患者。在 HCC 细胞系 HepG2 中敲除 LMNA 基因导致肿瘤发生能力降低,P16 表达上调,CDK1 表达下调。这些发现提示 LMNA 可能在 HCC 中作为癌基因发挥作用,并为 HCC 的诊断和治疗提供了一个新的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/d17d525d34f3/JCMM-24-12008-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/d4b4e05c42c9/JCMM-24-12008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/dfe34e910351/JCMM-24-12008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/664f6b06474f/JCMM-24-12008-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/26ebcdb86e10/JCMM-24-12008-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/3ef0dec911f9/JCMM-24-12008-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/00797ef49d7f/JCMM-24-12008-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/d17d525d34f3/JCMM-24-12008-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/d4b4e05c42c9/JCMM-24-12008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/dfe34e910351/JCMM-24-12008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/664f6b06474f/JCMM-24-12008-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/26ebcdb86e10/JCMM-24-12008-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/3ef0dec911f9/JCMM-24-12008-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/00797ef49d7f/JCMM-24-12008-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/737b/7578910/d17d525d34f3/JCMM-24-12008-g007.jpg

相似文献

1
LMNA functions as an oncogene in hepatocellular carcinoma by regulating the proliferation and migration ability.LMNA 通过调节肝癌的增殖和迁移能力发挥癌基因作用。
J Cell Mol Med. 2020 Oct;24(20):12008-12019. doi: 10.1111/jcmm.15829. Epub 2020 Sep 8.
2
CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.CRISPR/Cas9 介导的 NSD1 基因敲除通过 NSD1/H3/Wnt10b 信号通路抑制肝癌的发展。
J Exp Clin Cancer Res. 2019 Nov 14;38(1):467. doi: 10.1186/s13046-019-1462-y.
3
Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1.咪达唑仑通过升高 microRNA-124-3p 和抑制 PIM-1 来抑制肝癌细胞增殖并促进其凋亡。
IUBMB Life. 2020 Mar;72(3):452-464. doi: 10.1002/iub.2171. Epub 2019 Oct 25.
4
Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines.癌基因 PLCE1 可能通过影响肝癌细胞系的细胞周期、增殖、迁移和侵袭能力成为诊断和预后的生物标志物。
J Cell Physiol. 2020 Oct;235(10):7003-7017. doi: 10.1002/jcp.29596. Epub 2020 Feb 9.
5
MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.微小RNA-548a-5p通过靶向Tg737促进肝癌细胞增殖并抑制其凋亡。
World J Gastroenterol. 2016 Jun 21;22(23):5364-73. doi: 10.3748/wjg.v22.i23.5364.
6
Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.ATOH8 的缺失增加了肝癌细胞的干细胞特征。
Gastroenterology. 2015 Oct;149(4):1068-81.e5. doi: 10.1053/j.gastro.2015.06.010. Epub 2015 Jun 20.
7
Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.长链非编码 RNA AK021443 通过调控肝癌细胞上皮-间充质转化促进细胞增殖和迁移。
DNA Cell Biol. 2018 May;37(5):481-490. doi: 10.1089/dna.2017.4030. Epub 2018 Mar 14.
8
Cyclin Y Modulates the Proliferation, Invasion, and Metastasis of Hepatocellular Carcinoma Cells.周期蛋白 Y 调节肝癌细胞的增殖、侵袭和转移。
Med Sci Monit. 2018 Mar 20;24:1642-1653. doi: 10.12659/msm.906075.
9
XTP8 promotes hepatocellular carcinoma growth by forming a positive feedback loop with FOXM1 oncogene.XTP8 通过与 FOXM1 癌基因形成正反馈环促进肝癌生长。
Biochem Biophys Res Commun. 2019 Jul 30;515(3):455-461. doi: 10.1016/j.bbrc.2019.05.164. Epub 2019 Jun 1.
10
CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.环状 RNA(Hsa_circ_0000567)作为 microRNA-421 的海绵体抑制肝癌生长。
J Exp Clin Cancer Res. 2019 Feb 22;38(1):98. doi: 10.1186/s13046-019-1041-2.

引用本文的文献

1
Lamins regulate cancer cell plasticity and chemosensitivity.核纤层蛋白调节癌细胞的可塑性和化学敏感性。
Front Oncol. 2025 Jul 10;15:1599175. doi: 10.3389/fonc.2025.1599175. eCollection 2025.
2
Histone crotonylation in tumors (Review).肿瘤中的组蛋白巴豆酰化(综述)
Mol Clin Oncol. 2025 Mar 11;22(5):39. doi: 10.3892/mco.2025.2834. eCollection 2025 May.
3
Mitochondrial permeability transition drives the expression, identification and validation of necrosis-related genes in prognostic risk models of hepatocellular carcinoma.

本文引用的文献

1
Recent Advances in Immunotherapy for Hepatocellular Carcinoma.肝细胞癌免疫治疗的最新进展
Cancers (Basel). 2020 Mar 25;12(4):775. doi: 10.3390/cancers12040775.
2
Loss of an H3K9me anchor rescues laminopathy-linked changes in nuclear organization and muscle function in an Emery-Dreifuss muscular dystrophy model.缺失 H3K9me 锚定可挽救 Emery-Dreifuss 肌营养不良症模型中核组织和肌肉功能相关的核纤层蛋白病变化。
Genes Dev. 2020 Apr 1;34(7-8):560-579. doi: 10.1101/gad.332213.119. Epub 2020 Mar 5.
3
The past, present and future perspectives of matrix metalloproteinase inhibitors.
线粒体通透性转换驱动肝细胞癌预后风险模型中坏死相关基因的表达、鉴定及验证。
Transl Cancer Res. 2025 Feb 28;14(2):1037-1052. doi: 10.21037/tcr-24-1442. Epub 2025 Feb 26.
4
CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma.CRISPR在肝细胞癌的靶向治疗和过继性T细胞免疫治疗中的应用
J Hepatocell Carcinoma. 2024 May 30;11:975-995. doi: 10.2147/JHC.S456683. eCollection 2024.
5
Knockdown of inhibits Akt/β-catenin-mediated cell invasion and migration in clear cell renal cell carcinoma cells.敲低 抑制透明细胞肾细胞癌细胞中 Akt/β-catenin 介导的细胞侵袭和迁移。
Cell Adh Migr. 2023 Dec;17(1):1-14. doi: 10.1080/19336918.2023.2260644. Epub 2023 Sep 25.
6
GeNetOntology: identifying affected gene ontology terms via grouping, scoring, and modeling of gene expression data utilizing biological knowledge-based machine learning.基因本体论:通过利用基于生物知识的机器学习对基因表达数据进行分组、评分和建模来识别受影响的基因本体术语。
Front Genet. 2023 Aug 21;14:1139082. doi: 10.3389/fgene.2023.1139082. eCollection 2023.
7
Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma.基于肝细胞癌的CRISPR/Cas9基因编辑技术的研究进展与应用
Asian J Pharm Sci. 2023 Jul;18(4):100828. doi: 10.1016/j.ajps.2023.100828. Epub 2023 Jul 24.
8
Loss of Mature Lamin A/C Triggers a Shift in Intracellular Metabolic Homeostasis via AMPKα Activation.成熟型 lamin A/C 的缺失通过激活 AMPKα 引发细胞内代谢稳态的转变。
Cells. 2022 Dec 9;11(24):3988. doi: 10.3390/cells11243988.
9
Global crotonylome reveals hypoxia-mediated lamin A crotonylation regulated by HDAC6 in liver cancer.全球 crotonylome 揭示了缺氧介导的 lamin A crotonylation 受肝癌中 HDAC6 的调控。
Cell Death Dis. 2022 Aug 17;13(8):717. doi: 10.1038/s41419-022-05165-1.
10
Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma.肝细胞癌中microRNA-122的分子靶点及信号通路
Pharmaceutics. 2022 Jun 29;14(7):1380. doi: 10.3390/pharmaceutics14071380.
基质金属蛋白酶抑制剂的过去、现在和未来展望。
Pharmacol Ther. 2020 Mar;207:107465. doi: 10.1016/j.pharmthera.2019.107465. Epub 2019 Dec 18.
4
Review article: new therapeutic interventions for advanced hepatocellular carcinoma.综述文章:晚期肝细胞癌的新治疗干预措施。
Aliment Pharmacol Ther. 2020 Jan;51(1):78-89. doi: 10.1111/apt.15573. Epub 2019 Nov 20.
5
Economic Implications of Hepatocellular Carcinoma Surveillance and Treatment: A Guide for Clinicians.肝细胞癌监测与治疗的经济学意义:临床医生指南。
Pharmacoeconomics. 2020 Jan;38(1):5-24. doi: 10.1007/s40273-019-00839-9.
6
The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications.人类和小鼠肝细胞癌的免疫生物学:基本概念和治疗意义。
J Hepatol. 2020 Jan;72(1):167-182. doi: 10.1016/j.jhep.2019.08.014. Epub 2019 Aug 23.
7
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?中国当前癌症形势:2018 年全球癌症统计数据带来的是好消息还是坏消息?
Cancer Commun (Lond). 2019 Apr 29;39(1):22. doi: 10.1186/s40880-019-0368-6.
8
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
9
Correlations of breast cancer FHIT gene with the incidence and prognosis of breast cancer.乳腺癌FHIT基因与乳腺癌发病率及预后的相关性。
J BUON. 2019 Jan-Feb;24(1):40-47.
10
Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE.顺铂同步放化疗与西妥昔单抗生物放疗治疗p16阳性口咽癌的比较:一项纳入RTOG 1016和De-ESCALaTE试验的更新荟萃分析
Eur Arch Otorhinolaryngol. 2019 May;276(5):1275-1281. doi: 10.1007/s00405-019-05387-8. Epub 2019 Mar 18.